Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention Academic Article uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Anticoagulants
  • Embolism
  • Peptide Fragments
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Thrombosis

abstract

  • Provisional GP IIb/IIIa use in bivalirudin-treated patients is higher in contemporary non-emergent PCI practice than that seen in randomized trials and is associated with similar in-hospital ischemic events, but more frequent bleeding events. These data suggest that a strategy of bivalirudin monotherapy is preferable in order to reduce bleeding complications, and GP IIb/IIIa blockade should be reserved for patients with periprocedural complications in bivalirudin-treated patients undergoing PCI.

publication date

  • June 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 19494400

Additional Document Info

start page

  • 258

end page

  • 63

volume

  • 21

number

  • 6